PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.40%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-5.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-6.02%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-6.02%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-9.09%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-13.33%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-13.33%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
4.90%
Share change of 4.90% while STERV.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
4.90%
Slight or no buyback while STERV.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
2.90%
OCF growth under 50% of STERV.HE's 31.96%. Michael Burry might suspect questionable revenue recognition or rising costs.
-9.50%
Negative FCF growth while STERV.HE is at 41.92%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-36.02%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-12.26%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-2.71%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
377.72%
10Y OCF/share CAGR above 1.5x STERV.HE's 89.44%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-25.47%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
8.92%
3Y OCF/share CAGR above 1.5x STERV.HE's 5.49%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
11.18%
Positive 10Y CAGR while STERV.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
62.50%
Positive 5Y CAGR while STERV.HE is negative. John Neff might view this as a strong mid-term relative advantage.
18.18%
Positive short-term CAGR while STERV.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
17.24%
10Y equity/share CAGR at 50-75% of STERV.HE's 26.38%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
19.67%
Below 50% of STERV.HE's 47.13%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
16.32%
3Y equity/share CAGR at 50-75% of STERV.HE's 24.90%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.37%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.47%
Asset growth above 1.5x STERV.HE's 0.54%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.54%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.15%
We’re deleveraging while STERV.HE stands at 0.07%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-7.45%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.